American Society of Clinical Oncology

SHERPA: White

People

  1. Bosl
    Bosl
  2. Feldman
    Feldman
  3. Motzer
    Motzer
  4. Bajorin
    Bajorin
  5. Sheinfeld
    Sheinfeld
  6. Reuter
    Reuter
  7. Bains
    Bains
  8. Funt
    Funt
  9. Carousso
    Carousso
  10. Carver
    Carver

Groups

  1. Biostatistics Service (32)
  2. Epidemiology and Biostatistics (32)
  3. Survivorship Research (32)
  4. Department of Medicine (29)
  5. Genitourinary Oncology Service (29)
  6. Solid Tumor Oncology Division (29)
  7. Surgery (22)
  8. Urology (21)
  9. Nursing (11)
  10. Advanced Practice Providers (7)
Search Within
  1. "George Bosl"
  2. "Biostatistics Service"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (11)
Groups
  1. Biostatistics Service (32)
  2. Epidemiology and Biostatistics (32)
  3. Survivorship Research (32)
  4. Department of Medicine (29)
  5. Genitourinary Oncology Service (29)
  6. Solid Tumor Oncology Division (29)

More Groups

People
  1. George Bosl (32)
  2. Darren Feldman (27)
  3. Sujata Patil (26)
  4. Robert Motzer (23)
  5. Dean Bajorin (21)
  6. Joel Sheinfeld (21)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (4)
  5. 2017 (1)
  6. 2016 (3)

More Years

Publications
  1. Journal of Clinical Oncology (32)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort
    Meeting Abstract

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy with etoposide plus cisplatin for patients with pathologic stage II nonseminomatous germ cell tumors
    Journal Article

    McHugh, D. J.; Funt, S. A.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of teratoma on the cumulative incidence of disease-related death in patients with advanced germ cell tumors
    Journal Article

    Funt, S. A.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S. K.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Histologic determinants of long-term overall survival in patients (pts) with germ cell tumors (GCT)
    Meeting Abstract

    Funt, S.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors
    Journal Article

    Bagrodia, A.; Lee, B. H.; Lee, W.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Pietzak, E. J.; Gao, S. P.; Zabor, E. C.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save